AstraZeneca to cut 1,200 jobs in Delaware

Published



DOVER, Del. (AP) — Pharmaceutical company AstraZeneca PLC said Monday it would cut 1,200 jobs at its U.S. headquarters in Wilmington.

The U.K.-based pharmaceutical company said it was eliminating 1,600 jobs worldwide in a global restructuring of its research and development centers, to be completed by 2016. Small molecule and biologics R&D activities will be concentrated in Gaithersburg, Md., Cambridge, England, and Mölndal, Sweden.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.